Wesbanco Bank Inc Uro Gen Pharma Ltd. Transaction History
Wesbanco Bank Inc
- $2.82 Billion
- Q1 2025
A detailed history of Wesbanco Bank Inc transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Wesbanco Bank Inc holds 74,400 shares of URGN stock, worth $595,200. This represents 0.03% of its overall portfolio holdings.
Number of Shares
74,400
Previous 74,400
-0.0%
Holding current value
$595,200
Previous $792,000
5.18%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
142Shares Held
38.7MCall Options Held
91.4KPut Options Held
42.1K-
Rtw Investments, LP New York, NY3.83MShares$30.7 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$25.7 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$18.4 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$17.6 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY2.15MShares$17.2 Million1.7% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $182M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...